Skip to main content

Table 2 Median AUC of the symptom scores, medication scores and combined SMS for the 21 day observation period during main birch pollen exposure in each of the two seasons

From: Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial

  rBet v 1-FV Comparator Wilcoxon–Mann–Whitney U-Test
  median (IQR) median (IQR) p-values
First treatment year    
Symptom score 3.10 (9.36) 5.69 (4.71) 0.400
Medication score 1.43 (3.10) 2.83 (5.75) 0.285
SMS 5.86 (14.02) 12.40 (9.32) 0.330
Second treatment year    
Symptom score 2.81 (4.02) 1.67 (2.41) 0.393
Medication score 0.29 (1.36) 1.05 (3.50) 0.730
SMS 3.00 (6.50) 2.93 (4.86) 0.812